GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » PS Ratio

Chordate Medical Holding AB (OSTO:CMH) PS Ratio : 11.04 (As of Jun. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Chordate Medical Holding AB's share price is kr0.0552. Chordate Medical Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.01. Hence, Chordate Medical Holding AB's PS Ratio for today is 11.04.

Good Sign:

Chordate Medical Holding AB stock PS Ratio (=10.4) is close to 3-year low of 9.84

The historical rank and industry rank for Chordate Medical Holding AB's PS Ratio or its related term are showing as below:

OSTO:CMH' s PS Ratio Range Over the Past 10 Years
Min: 9.84   Med: 119.24   Max: 337.58
Current: 11.04

During the past 9 years, Chordate Medical Holding AB's highest PS Ratio was 337.58. The lowest was 9.84. And the median was 119.24.

OSTO:CMH's PS Ratio is ranked worse than
83.35% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 3.18 vs OSTO:CMH: 11.04

Chordate Medical Holding AB's Revenue per Sharefor the three months ended in Mar. 2024 was kr0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.01.

Warning Sign:

Chordate Medical Holding AB revenue per share has been in decline for the last 5 years.

During the past 3 years, the average Revenue per Share Growth Rate was -24.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was -52.60% per year.

During the past 9 years, Chordate Medical Holding AB's highest 3-Year average Revenue per Share Growth Rate was 158.40% per year. The lowest was -68.20% per year. And the median was -40.15% per year.

Back to Basics: PS Ratio


Chordate Medical Holding AB PS Ratio Historical Data

The historical data trend for Chordate Medical Holding AB's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB PS Ratio Chart

Chordate Medical Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only - - - 395.68 40.61

Chordate Medical Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 117.72 40.61 13.54

Competitive Comparison of Chordate Medical Holding AB's PS Ratio

For the Medical Devices subindustry, Chordate Medical Holding AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordate Medical Holding AB's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's PS Ratio distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's PS Ratio falls into.



Chordate Medical Holding AB PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Chordate Medical Holding AB's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0552/0.005
=11.04

Chordate Medical Holding AB's Share Price of today is kr0.0552.
Chordate Medical Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Chordate Medical Holding AB  (OSTO:CMH) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Chordate Medical Holding AB PS Ratio Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordate Medical Holding AB (OSTO:CMH) Business Description

Traded in Other Exchanges
Address
c/o Regus, Kistagangen 20B, Kista, SWE, 164 40
Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines